As per recent market analysis, the global critical care drugs industry size is on an upward trajectory, foreseeing a steady Compound Annual Growth Rate (CAGR) ranging from 5% to 6% from 2022 to 2032. Projections indicate substantial revenue generation by the conclusion of this forecast period. The escalating prevalence of diverse chronic ailments worldwide has …